Miltenyi Biotec reached a clean operations status at its MBCP facility after cleaning, commissioning, and checklists.
Public source
Publisher name
Public post
MBCP: Hard hats make way for hair nets I am happy to share that, after a great deal of cleaning, commissioning and probably more detailed checklists than anyone would ca…
Company
Miltenyi Biotec
- Industry
- Biotechnology Research
- Location
- Bergisch Gladbach, DE
- Company size
- 1,001–5,000 employees
About Miltenyi Biotec
For over 35 years, we have been developing cutting-edge science and technology to empower biomedical research and personalized medicine. We combine excellence from more than 60 disciplines in natural sciences, engineering, and informatics to make a significant contribution to biomedical sciences. We encourage a creative working environment driven by pioneering spirit – to seek new horizons – boldly envisioning the future and turning it into reality. Today, more than 5,000 experts from over 75 countries contribute to our sustainable success.
See moreLatest activity
Latest activity from Miltenyi Biotec
4 signals
Presence & Recognition
Miltenyi Biotec spoke about Stelvio at the 2026 Cyc26 conference.
People
Miltenyi Biotec appointed Pradipto Kolay as Global Head of R&D Engineering and Chief Technology Officer (CTO).
People
Miltenyi Biotec employee Kevin Z. Chen attended Cell Separation Specialist training in San Diego to learn about the autoMACS® NEO Separator.
Discover more
Similar signals
Similar public activity from other companies.
Operations & Supply
Merck Life Science
Merck Life Science established a new BioReliance testing facility in Darmstadt, Germany, with Alicia, an analytical and biosafety scientist, helping to establish the facility.
Operations & Supply
MilliporeSigma
MilliporeSigma established a new BioReliance testing facility in Darmstadt, Germany, with Alicia, an analytical and biosafety scientist, helping to establish the facility.
Operations & Supply
Genentech
Genentech officially reached a key construction milestone by topping out its new 700,000-square-foot biomanufacturing facility in Holly Springs, North Carolina.
Operations & Supply
NHSBT Cellular & Molecular Therapies
NHSBT Cellular & Molecular Therapies consolidated two viral vector manufacturing rooms into one using a new hatch to improve material and personnel flow while maintaining GMP requirements.
Operations & Supply
ANDOCKSYSTEME